Skip to Main Content

Author Details

Randall Merchant
Virginia Commonwealth University
1977
86
30
PMIDPaper TitleJournal TitlePublished Year
38091011Clinical Outcomes After Traumatic Brain Injury and Exposure to Extracranial Surgery: A TRACK-TBI Study.JAMA Surg2024
34279565Pathological Computed Tomography Features Associated With Adverse Outcomes After Mild Traumatic Brain Injury: A TRACK-TBI Study With External Validation in CENTER-TBI.JAMA Neurol2021
33822070Association of Sex and Age With Mild Traumatic Brain Injury-Related Symptoms: A TRACK-TBI Study.JAMA Netw Open2021
33783518Latent Profile Analysis of Neuropsychiatric Symptoms and Cognitive Function of Adults 2 Weeks After Traumatic Brain Injury: Findings From the TRACK-TBI Study.JAMA Netw Open2021
34964854Association of Posttraumatic Epilepsy With 1-Year Outcomes After Traumatic Brain Injury.JAMA Netw Open2021
34228047Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI Study.JAMA Neurol2021
30375265Response to Foks et al. (doi: 10.1089/neu.2018.5979): Why Our Long-Term Functional Prognosis Tools are a Valuable Contribution to the Traumatic Brain Injury Outcome Literature.J Neurotrauma2019
30234849Using Decision Tree Methodology to Predict Employment After Moderate to Severe Traumatic Brain Injury.J Head Trauma Rehabil2019
31157856Recovery After Mild Traumatic Brain Injury in Patients Presenting to US Level I Trauma Centers: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Study.JAMA Neurol2019
29566600Predicting Long-Term Global Outcome after Traumatic Brain Injury: Development of a Practical Prognostic Tool Using the Traumatic Brain Injury Model Systems National Database.J Neurotrauma2018
30646055Assessment of Follow-up Care After Emergency Department Presentation for Mild Traumatic Brain Injury and Concussion: Results From the TRACK-TBI Study.JAMA Netw Open2018
29421963Making Football Safer: Assessing the Current National Football League Policy on the Type of Helmets Allowed on the Playing Field.J Neurotrauma2018
25841982Altered white matter in cocaine-dependent subjects with traumatic brain injury: A diffusion tensor imaging study.Drug Alcohol Depend2015
26485478Nutritional Supplementation with Chlorella pyrenoidosa Lowers Serum Methylmalonic Acid in Vegans and Vegetarians with a Suspected Vitamin B⿁⿿ Deficiency.J Med Food2015
25285596The effect of oral care on intracranial pressure in critically ill adults.J Neurosci Nurs2014
23168823Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).JAMA2012
19803786The citicoline brain injury treatment (COBRIT) trial: design and methods.J Neurotrauma2009
15933813Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas.J Neurooncol2005
12864971Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery.J Neuroimmunol2003
12952285Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression.J Neurooncol2003
12012105Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination.Cancer Immunol Immunother2002
15916412Outcome measures for clinical trials in neurotrauma.Neurosurg Focus2002
12635661Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat.J Neurooncol2002
12495586Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension.J Med Food2002
12012106Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression.Cancer Immunol Immunother2002
11123284IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity.J Immunol2001
11347287A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis.Altern Ther Health Med2001
11570581Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis.Cancer Immunol Immunother2001
10815009Nutritional supplementation with Chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study.Phytother Res2000
10668412A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury.Ann N Y Acad Sci1999
10845391Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats.J Neurooncol1999
10668413An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage.Ann N Y Acad Sci1999
9049859Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes.J Neurooncol1997
9176405Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.Am J Pathol1997
9175143Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes.Neurol Res1997
9006660Effects of an intratumoral injection of human recombinant tumor necrosis factor-alpha on cerebrovascular permeability and leukocytic infiltration in a rat glioma model.Acta Neuropathol1997
9049860Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes.J Neurooncol1997
7825184The effects of acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on glioma-specific cytotoxic T-cell activity in Fischer 344 rats.Toxicology1995
7807180Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat.J Neurooncol1994
8121549Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines.Neurosurgery1994
1285500Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-alpha in the rat.Acta Neuropathol1992
1641114Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma.Neurosurgery1992
1739983Corticosteroids inhibit the delivery of short-term activational pulses of phorbol ester and calcium ionophore to human peripheral T cells.Cell Immunol1992
1613537Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.J Neurooncol1992
1541981Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial.J Neurooncol1992
1730954In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect.J Neurosurg1992
1367404A comparison of serum-free media for the support of in vitro mitogen-induced blastogenic expansion of cytolytic lymphocytes.Cytotechnology1991
1874974Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats.J Neuroimmunol1991
1716671Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.J Neurooncol1991
2089914Effect of murine recombinant interleukin-1 on brain oedema in the rat.Acta Neurochir Suppl (Wien)1990
  • 1 - 50 of 86

Recommended Authors

0The Alfred Hospital
Career Start Year 1997
Number of shared co-authors 4
Case Western Reverse University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1994
Number of shared co-authors 0
Duke Cancer Institute
Career Start Year 1991
Number of shared co-authors 0
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
9Virginia Commonwealth University
Career Start Year 1988
Number of shared co-authors 1
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 0
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 0
National Institute of Neurological Disorders and Stroke
Career Start Year 1986
Number of shared co-authors 2
Rutgers Cancer Institute of New Jersey, Rutgers University
Career Start Year 1984
Number of shared co-authors 0
and Clinical Center, Central Arkansas Veterans Healthcare System
Career Start Year 1984
Number of shared co-authors 1
University Hospital Zurich
Career Start Year 1982
Number of shared co-authors 0
University of Wisconsin School of Medicine and Public Health
Career Start Year 1980
Number of shared co-authors 0
National Institutes of Health
Career Start Year 1979
Number of shared co-authors 0
National Institute of Mental Health
Career Start Year 1978
Number of shared co-authors 0
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 0
Cellstan-Immunoquant Inc.
Career Start Year 1977
Number of shared co-authors 1
University of California san francisco
Career Start Year 1975
Number of shared co-authors 2
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1975
Number of shared co-authors 0
University of Texas M.D. Anderson Cancer Center
Career Start Year 1974
Number of shared co-authors 0
Henry Ford Hospital
Career Start Year 1973
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 0
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year 1970
Number of shared co-authors 1
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 1
University of Virginia School of Medicine
Career Start Year 1966
Number of shared co-authors 0
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1965
Number of shared co-authors 3
University of Colorado School of Medicine
Career Start Year 1961
Number of shared co-authors 0
Mount Sinai Hospital
Career Start Year 1943
Number of shared co-authors 0

Collaborators

University of Pennsylvania
Co-authored papers 10
University of Washington
Co-authored papers 9
Spaulding Rehabilitation Hospital, Harvard Medical School
Co-authored papers 9
Baylor College of Medicine
Co-authored papers 8
Baylor College of Medicine
Co-authored papers 8
Center for Neurotrauma Research, Medical College of Wisconsin
Co-authored papers 8
University of California san francisco
Co-authored papers 8
University of Washington
Co-authored papers 8
Miller School of Medicine, University of Miami
Co-authored papers 8
University of Maryland, University of Maryland Medical Center
Co-authored papers 8
University of Pittsburgh Medical Center
Co-authored papers 7
The University of Texas at Austin
Co-authored papers 7
University of California San Diego
Co-authored papers 7
VA San Diego Healthcare System (VASDHS)
Co-authored papers 7
University of California san francisco
Co-authored papers 7
University of California san francisco
Co-authored papers 7
Baylor College of Medicine
Co-authored papers 7
University of Cincinnati
Co-authored papers 7
University of Texas Southwestern Medical Center
Co-authored papers 7
Mass General Hospital for Children
Co-authored papers 7
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Co-authored papers 7
University of California san francisco
Co-authored papers 7
Spaulding Rehabilitation Hospital
Co-authored papers 7
University of California san francisco
Co-authored papers 7
University of California san francisco
Co-authored papers 7
University of California san francisco
Co-authored papers 7
University of Texas Southwestern Medical Center
Co-authored papers 7
University of Miami
Co-authored papers 6
University of Michigan ann arbor
Co-authored papers 6
University of California san francisco
Co-authored papers 6